-
10565-100NVP-BEZ235-100 mg
Price: $353.84List Price: $393.15A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays disease stasis when administered orally, and enhances the efficacy of other anti-cancer agents when used in in vivo combination studies inhibits PI3K isoforms and mutants -
10565-25NVP-BEZ235-25 mg
Price: $220.67List Price: $245.19A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays disease stasis when administered orally, and enhances the efficacy of other anti-cancer agents when used in in vivo combination studies inhibits PI3K isoforms and mutants -
10565-250NVP-BEZ235-250 mg
Price: $939.91List Price: $1,044.35A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays disease stasis when administered orally, and enhances the efficacy of other anti-cancer agents when used in in vivo combination studies inhibits PI3K isoforms and mutants -
10565-50NVP-BEZ235-50 mg
Price: $331.56List Price: $368.40A potent dual inhibitor of PI3K and mTOR that is well tolerated, displays disease stasis when administered orally, and enhances the efficacy of other anti-cancer agents when used in in vivo combination studies inhibits PI3K isoforms and mutants -
O647060-10mgObeldesivir (C007B-381817)
Price: $1,168.66List Price: $1,298.51Obeldesivir (ATV006) is a potent, orally active antiviral agent and ester proagents of GS-441524. Obeldesivir inhibits the replication of SARS-CoV-2 and its variants. Obeldesivir can be used for SARS-CoV-2 research.In VitroObeldesivir (0.001-100 μM: -
O647060-25mgObeldesivir (C007B-381818)
Price: $2,221.83List Price: $2,468.70Obeldesivir (ATV006) is a potent, orally active antiviral agent and ester proagents of GS-441524. Obeldesivir inhibits the replication of SARS-CoV-2 and its variants. Obeldesivir can be used for SARS-CoV-2 research.In VitroObeldesivir (0.001-100 μM: -
O647060-50mgObeldesivir (C007B-381819)
Price: $3,390.66List Price: $3,767.40Obeldesivir (ATV006) is a potent, orally active antiviral agent and ester proagents of GS-441524. Obeldesivir inhibits the replication of SARS-CoV-2 and its variants. Obeldesivir can be used for SARS-CoV-2 research.In VitroObeldesivir (0.001-100 μM: -
O647060-5mgObeldesivir (C007B-381820)
Price: $730.82List Price: $812.03Obeldesivir (ATV006) is a potent, orally active antiviral agent and ester proagents of GS-441524. Obeldesivir inhibits the replication of SARS-CoV-2 and its variants. Obeldesivir can be used for SARS-CoV-2 research.In VitroObeldesivir (0.001-100 μM: -
Ab182846-100μgOlinvacimab (anti-VEGFR2) (C007B-446371)
Price: $176.80List Price: $196.44Olinvacimab (anti-VEGFR2) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab (anti-VEGFR2) inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab (anti-VEGFR2) has antiangiogenic activity. Olinvacimab (anti-VEGFR2) can be used -
Ab182846-10mgOlinvacimab (anti-VEGFR2) (C007B-446372)
Price: $2,805.08List Price: $3,116.75Olinvacimab (anti-VEGFR2) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab (anti-VEGFR2) inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab (anti-VEGFR2) has antiangiogenic activity. Olinvacimab (anti-VEGFR2) can be used -
Ab182846-1mgOlinvacimab (anti-VEGFR2) (C007B-446373)
Price: $695.55List Price: $772.84Olinvacimab (anti-VEGFR2) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab (anti-VEGFR2) inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab (anti-VEGFR2) has antiangiogenic activity. Olinvacimab (anti-VEGFR2) can be used -
Ab182846-5mgOlinvacimab (anti-VEGFR2) (C007B-446374)
Price: $1,824.20List Price: $2,026.89Olinvacimab (anti-VEGFR2) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab (anti-VEGFR2) inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab (anti-VEGFR2) has antiangiogenic activity. Olinvacimab (anti-VEGFR2) can be used
Bevacizumab
Browse our curated selection of Bevacizumab from leading global manufacturers. Find research-grade reagents, certified standards, and specialty supplies backed by Cenmed's expert sourcing and technical support.
About Bevacizumab
Cenmed Enterprises provides a comprehensive selection of Bevacizumab products sourced from leading global manufacturers. Our catalog spans research-grade reagents, certified standards, and specialty compounds used across clinical, academic, and industrial laboratories worldwide.
With decades of expertise in laboratory supply distribution, we offer competitive pricing, reliable stock availability, and dedicated technical support. Whether you need small quantities for research or bulk orders for manufacturing, our team is ready to assist with sourcing, compliance documentation, and logistics.



